Apr.19
10:46 AM ET
Thursday, 19 Apr 2012
Based on my discussions with several analysts, from reading their reports, I suspect that the earnings revisions occurred after the analysts had conversations with Mylan. Read More
Topics:SEC | Earnings | Medicine | Investment Strategy | Nasdaq Composite | NYSE | Stock Market | Stock Picks
Sectors:Pharmaceuticals | Health Care
Companies:Mylan Laboratories Inc
Apr.19
10:44 AM ET
Thursday, 19 Apr 2012
In 2011, Mylan’s longtime chief executive Robert Coury, who gave up the post at the end of the year to become executive chairman (he’s also chairman of the board) earned cash compensation of $7.4 million. Read More
Topics:Executive Compensation | Investment Strategy | Nasdaq Composite | NYSE | Stock Market | Stock Picks
Sectors:Pharmaceuticals | Health Care
Companies:Bristol-Myers Squibb Co | Pfizer Inc | Mylan Laboratories Inc
Mar.16
12:05 PM ET
Friday, 16 Mar 2012
When Mylan Inc. held its analyst day a few weeks ago, it offered an earnings per share forecast for (wait for it!) 2018. Read More
Topics:Accounting | Investing | Investment Strategy | Nasdaq Composite | NYSE | Stock Market | Stock Picks
Companies:IBM | GlaxoSmithKline plc | Pfizer Inc | Mylan Laboratories Inc
Mar.08
6:48 PM ET
Thursday, 8 Mar 2012
Some of the steadiest growth stocks lie in pharmaceuticals and agricultural plays, one noted investor said Thursday. Read More
VIDEO | COMPANIES : Mylan Laboratories Inc
Chris Viehbacher, CEO, Sanofi says the firm has been built so that it could grow without having to rely on the research ...
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Mad Money's Jim Cramer answers live viewer "tweets" and emails on stock and investment questions.
More VideosNews |
COMPANY : Mylan Laboratories Inc
Posted By:
| Source: CNBC.com
Source: Reuters
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
